Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trialsDonald A Berry, Naoto T Ueno, Marcella M Johnson, et al.
Therapeutic Drug Monitoring|October 10, 2018
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug MonitoringSotheara Moeung, Christine Chevreau, Vianney Poinsignon, et al.
BMC Cancer|December 24, 2014
Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulabilityMourad Chaari, Ines Ayadi, Aurelie Rousseau, et al.
Gynecologic Oncology|November 19, 2022
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trialBenoit You, Pierre-Adrien Bolze, Jean-Pierre Lotz, et al.
Oncology Letters|March 22, 2016
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort studyFrédéric Selle, George Emile, Patricia Pautier, et al.
World Journal of Surgical Oncology|January 13, 2018
Male breast cancer: diagnosis stages, treatment and survival in a country with limited resources (Burkina Faso)Nayi Zongo, Smaïla Ouédraogo, Nina Korsaga-Somé, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2020
Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II TrialBenoit You, Pierre-Adrien Bolze, Jean-Pierre Lotz, et al.
International Journal of Oncology|July 30, 2009
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancerFrançois M Lemoine, Mustapha Cherai, Camille Giverne, et al.
Cancer Medicine|March 6, 2021
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumorsChristine Chevreau, Christophe Massard, Aude Flechon, et al.
JAMA Oncology|June 11, 2026
Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors: The TROPHAMET Phase 1/2 Nonrandomized Clinical TrialBenoit You, Jean-Pierre Lotz, Pierre Descargues, et al.
Pageof 9